IMMUDEX

Serial Number 79333739
Registration 7282161
700

Registration Progress

Application Filed
Dec 10, 2021
Under Examination
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered
Jan 23, 2024

Trademark Image

IMMUDEX

Basic Information

Serial Number
79333739
Registration Number
7282161
Filing Date
December 10, 2021
Registration Date
January 23, 2024
Published for Opposition
November 7, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 23, 2024
Registration
Registered
Classes
001 005 042

Rights Holder

Immudex ApS

99
Address
Bredevej 2A
DK-2830 Virum
DK

Ownership History

Immudex ApS

Original Applicant
99
DK

Immudex ApS

Owner at Publication
99
DK

Immudex ApS

Original Registrant
99
DK

Legal Representation

Attorney
Miriam D. Trudell

USPTO Deadlines

Next Deadline
1551 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-23)
Due Date
January 23, 2030
Grace Period Ends
July 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

39 events
Date Code Type Description Documents
Nov 13, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Nov 13, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 13, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 13, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 24, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 23, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 23, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 6, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Oct 18, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 18, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 5, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 4, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 4, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 4, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Aug 6, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jul 19, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jul 19, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jul 6, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 6, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 6, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Jun 5, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 27, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 2, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Nov 14, 2022 RFNT P REFUSAL PROCESSED BY IB Loading...
Oct 27, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Oct 27, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Sep 2, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 1, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 24, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 26, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 17, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Chemicals used in industry and science, in the nature of immune related chemicals for immune cell analysis, immune cell monitoring, immune cell detection and immune cell stimulation and immune related chemicals used in science in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; diagnostic reagents for diagnostic being research use, other than medical and veterinary use, and scientific use; research diagnostic reagents for scientific use; diagnostic test materials for scientific and diagnostic, other than medical and veterinary, purposes, namely, diagnostic reagents and preparations, except for medical or veterinary use; diagnostic kits for scientific and diagnostic, other than medical and veterinary, purposes comprised of diagnostic reagents and preparations, except for medical or veterinary use and also comprised of immune related chemicals used in science, in the nature of MHC monomer and multimer reagents, MR1 monomer and multimer reagents, CD1 monomer and multimer reagents, antibodies, antigen monomer and multimer reagents, reagents, diagnostic agents, control reagents, oligonucleotide conjugated multimer reagents in the nature of DNA/RNA oligo conjugated multimer reagents; assays for research purposes; biochemical reagents for non- medical purposes, other than medical and veterinary; chemical and diagnostic preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB- vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for use in scientific research in connection with therapy and immunotherapy, in particular, for use in cancer therapy, cancer immunotherapy, for analysis of T-cell lymphoma, T-cell infiltration of solid tumors and tissue; chemical, and diagnostic preparations for analysis for research purposes related to analysis of infectious diseases, autoimmunity and for use in scientific research in connection with toxicological studies, transplantation, immune monitoring, and vaccines and T-cell monitoring; chemical reagents for other than medicinal and veterinary purposes
Class 005
Preparations for pharmaceutical purposes, namely, pharmaceutical preparations for the treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes, namely, diagnostic preparations for medical purposes and medical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T- cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; vaccines; diagnostic preparations for analysis for medical purposes, hereunder for each of the abovementioned preparations for medical analysis of vaccines, immunotherapeutics and cellular therapies, in particular cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV- vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy or other therapy, for medical analysis and treatment of T- cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases; diagnostic preparations for analysis for medical purposes, hereunder for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T-cell monitoring
Class 042
Scientific and technological services, namely, scientific research, analysis and testing in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific research; scientific research services, namely, diagnostic services related to research; analysis of medicine, pharmaceuticals and vaccines of others to assure compliance with industry standards; industrial research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; basic scientific research and clinical scientific research, hereunder for medicine and vaccine development; product research and development in the field of diagnostic preparations

Additional Information

Design Mark
The mark consists of the stylized wording "IMMUDEX" wherein the letters are colored blue, and the dot of the letter "I" is colored orange.
Color Claim
The color(s) blue and orange is/are claimed as a feature of the mark.

Classification

International Classes
001 005 042